Healthcare Stock Forecast: How to Invest in Healthcare after the Pandemic?

Meiru ZhongThis Healthcare Stock Forecast article was written by Meiru Zhong – Financial Analyst at I Know First.

Summary

  • US healthcare spending is expected to reach $6.2 trillion, accounting for 20% of GDP by 2028.
  • The most important trends and themes include the transition to value-based care, digital healthcare, pattern cycle dilemma, and focus on companies with pricing power.
  • Investment in subsectors, like managed care, medical devices, life-sciences tools, pharma, and biotech, should be prioritized in portfolios.
  • Investors should pick out companies that have sustainable innovation and pricing power.

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

PDSB Stock Forecast: Growing Pipeline Brings Results Driving Target Price To $20

NicoleThis PDSB stock forecast article was written by Nicole Shammay – Analyst at I Know First.

Summary:

  • PDSB releases interim data for clinical study revealing 67% tumor reduction
  • Announcement of oncology research and development day  
  • PDS Biotechnology deserves a one-year target price range of $17 to $20

premiumRead The Full Premium Article
Subscribe to receive exclusive PREMIUM content here

NVAX Stock Forecast: Global Rollout Of Covid-19 Vaccines & Buy Rating

Viktoria VoronchukThis NVAX stock prediction article was written by Viktoriya Voronchuk – Financial Analyst intern I Know First.

Summary:

  • Over the past month, the NVAX stock is up 69%: Investors believe Novavax is a major competitor for the vaccine from covid-19
  • Novavax spent 113,84 thousand $ on research and development: more than competitors in the biotech sector
  • The average growth rate for the last 8 years shows that NVAX 's stock target price should be around 145.15 $ for the next year

premiumRead The FullPremium Article

Subscribe to receive exclusive PREMIUM content here

I Know First Weekly Review Algorithmic Performance: July 29th, 2020

I Know First Weekly Newsletter
Investment Selection Using AI Predictive Algorithm
July 29, 2020

Read The Full Newsletter

Winning Stock Forecast: RGEN Gains 15.8% in 14 Days

Repligen
(source : www.stockwinners.com)

Over the period of June 16th to June 30th, Repligen Corporation (RGEN) stocks prices jumped by 15.8% in 14 days in agreement with the bullish I Know First forecast. Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is the leading manufacturer of Protein A affinity ligands, a critical component of Protein A resins that are used to separate and purify monoclonal antibody therapeutics

Read More

Exelixis Stock Forecast: The Future Of Cancer Medicine With Promising Financial Growth

Ori HoltzmanThis article was written by Ori Holtzman, a Financial Analyst at I Know First

Summary:

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

How Biotech Freed Itself From FDA Shackles: Trevena’s 108.72% Stock Rise

This article was written by Graham Ellinson, a Financial Analyst at I Know First currently studying Mathematics at Northumbria University Newcastle.

 

 Source: logosandbrands.directory

Highlights

      • OLINVO and other pipeline products drive TRVN growth
      • The rate of FDA drug approval has risen significantly across the board over the last year
      • I Know First algorithm is currently bullish on TRVN

      • premiumRead The Full Premium Article

        Subscribe to receive exclusive PREMIUM content Here

Pages:1234567»